be_ixf;ym_202208 d_10; ct_50

Select Page

Latest Insights on GRFS

erratic biotech stocks This New Strategy Makes Sense of Biotechs’ Erratic Moves I find one type of stock equal parts frustrating and fascinating — biotechs.

Newsletter Sign Up

Sponsored

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

“At the end of August [2018], my 401K was $659,000. Now, on September 4th [2018], it’s $715,000. My account is up $56,000 in the last 5 days!”

- Warren O

“I bought my first Of Paul’s stocks Nov. 1, 2017. I’m happy to say that I’m ahead $14,000. That’s more then 1/3 of what I invested with my money, and in 9 months. Thank you, Paul, you’re the real deal.”

- Larry

Share This